26 Results

People

  1. Riely
    Riely
  2. Kris
    Kris
  3. Ladanyi
    Ladanyi
  4. Drilon
    Drilon
  5. Arcila
    Arcila
  6. Chaft
    Chaft
  7. Paik
    Paik
  8. Sima
    Sima
  9. Wang
    Wang
  10. Benayed
    Benayed

Groups

  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (22)
  3. Thoracic Oncology (19)
  4. GSK Faculty (10)
  5. Human Oncology and Pathogenesis Program (9)
  6. Hematologic Malignancies, Division of (7)
  7. Population Sciences Research Program (5)
  8. Body Imaging Service (4)
  9. Radiology, Department of (4)
  10. Biostatistics Service (3)
Refine Results
  1. "anaplastic lymphoma kinase"
  2. "Department of Medicine"
Formats
  1. Journal Article (26)
Groups
  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (22)
  3. Thoracic Oncology (19)
  4. GSK Faculty (10)
  5. Human Oncology and Pathogenesis Program (9)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Gregory Riely (9)
  2. Marc Ladanyi (8)
  3. Mark Kris (8)
  4. Alexander Drilon (5)
  5. Maria Arcila (4)
  6. Camelia Sima (3)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (3)
  4. 2018 (1)
  5. 2017 (2)
  6. 2015 (6)

More Years

Publications
  1. Annals of Oncology (3)
  2. Cancer (2)
  3. Journal of Thoracic Oncology (2)
  4. American Society of Clinical Oncology Educational Book (1)
  5. Blood (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Oxford University Press (4)
  2. Elsevier Inc. (3)
  3. American Association for Cancer Research (2)
  4. American Society of Clinical Oncology (2)
  5. Nature Publishing Group (2)
  6. Wiley Blackwell (2)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
    Journal Article

    Kyi, C.; Friedman, C. F.; Mueller, J. J.; Benayed, R.; Ladanyi, M.; Arcila, M.; Yang, S. R.; Hensley, M. L.; Chiang, S.
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
    Journal Article

    Ross, D. S.; Liu, B.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Complete pathological response to crizotinib in a patient with ALK-rearranged lung adenocarcinoma
    Journal Article

    Mattar, M. S.; Chang, J.; Benayed, R.; Halpenny, D.; Powers, A.; Kleiner, D. E.; Drilon, A.; Kris, M. G.
    Clinical Lung Cancer (2020)

    Fulltext@MSK | Save
  • Efficacy of platinum/pemetrexed combination chemotherapy in ALK-positive NSCLC refractory to second-generation ALK inhibitors
    Journal Article

    Lin, J. J.; Schoenfeld, A. J.; Zhu, V. W.; Yeap, B. Y.; Chin, E.; Rooney, M.; Plodkowski, A. J.; Digumarthy, S. R.; Dagogo-Jack, I.; Gainor, J. F.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Brigatinib in patients With alectinib-refractory ALK-positive NSCLC
    Journal Article

    Lin, J. J.; Zhu, V. W.; Schoenfeld, A. J.; Yeap, B. Y.; Saxena, A.; Ferris, L. A.; Dagogo-Jack, I.; Farago, A. F.; Taber, A.; Traynor, A.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Expanding the portfolio of anaplastic lymphoma kinase inhibitors for anaplastic lymphoma kinase-rearranged lung cancers
    Journal Article

    Santini, F. C.; Salhab, R. M.; Sharma, S.; Drilon, A.
    Translational Cancer Research (2017)

    Fulltext@MSK | Save
  • Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer
    Journal Article

    Dagogo-Jack, I.; Shaw, A. T.; Riely, G. J.
    Clinical Pharmacology & Therapeutics (2017)

    Fulltext@MSK | Save
  • Alopecia in patients treated with molecularly targeted anticancer therapies
    Journal Article

    Belum, V. R.; Marulanda, K.; Ensslin, C.; Gorcey, L.; Parikh, T.; Wu, S.; Busam, K. J.; Gerber, P. A.; Lacouture, M. E.
    Annals of Oncology (2015)

    Fulltext@MSK | Save
  • Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors
    Journal Article

    Davare, M. A.; Vellore, N. A.; Wagner, J. P.; Eide, C. A.; Goodman, J. R.; Drilon, A.; Deininger, M. W.; O'Hare, T.; Druker, B. J.
    Proceedings of the National Academy of Sciences of the United States of America (2015)

    Fulltext@MSK | Save